163
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Existence of Compensatory Defense Mechanisms Against Oxidative Stress and Hypertension in Preeclampsia

, , , , , , & show all
Pages 21-37 | Published online: 04 Feb 2010
 

Abstract

Objective: Preeclampsia is a complex obstetrical syndrome characterized by hypertension and proteinuria. This syndrome is associated with oxidative stress, antioxidant imbalance and impaired production of vasoactive eicosanoids such as thromboxane A2 (TXA2), a potent vasoconstrictor, and prostacyclin (PGI2), a well-known vasodilator. We hypothesized that there was a relationship between antioxidant vitamins, such as vitamin E and coenzyme Q10 (CoQ10), and the production of vasoactive eicosanoids— PGI2 and TXA2—potentially regulated by pro-oxidants and antioxidants in preeclampsia. Methods: Therefore, the plasma levels of vitamin E, CoQ10, TXA2 and PGI2 in normotensive (n = 30) and preeclamptic (n = 29) pregnancies were evaluated. Reduced and oxidized forms of vitamin E and CoQ10 in blood were measured using a HPLC coupled to electrochemical detection. The levels of TXB2 and 6-keto-PGF, stable metabolites of TXA2 and PGI2 respectively, were measured by ELISA. Results: The CoQ10 oxidized/reduced ratio was significantly higher in preeclamptic compared to normotensive pregnancies (p = 0.04). A strong correlation between plasma levels of reduced vitamin E and CoQ10, corrected for apolipoprotein B, was observed only in preeclampsia (r = 0.69, p < 0.0001). The 6-keto-PGF/TXB2 ratio was higher in preeclampsia than in controls (p = 0.02), and this ratio was correlated to the oxidized/reduced ratio of both, vitamin E and CoQ10 in all pregnancies (p <0.023). Conclusion: The data indicated that CoQ10 is a sensitive marker of oxidative stress in preeclampsia. The correlation between vitamin E and CoQ10 suggested a coordinated defense mechanism against oxidation. Furthermore, the higher 6-keto-PGF/TXB2 ratio that strongly correlated with oxidative stress markers, suggests a mechanism developed by the maternal cardiovascular system to counteract hypertension during preeclampsia.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.